Literature DB >> 2895596

Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.

J G Stone1, P Foëx, J W Sear, L L Johnson, H J Khambatta, L Triner.   

Abstract

In a non-double-blind, prospective, randomized study, the intra-operative electrocardiograms of 128 mildly hypertensive surgical patients were examined in order to determine the incidence of myocardial ischemia during anesthesia. No patient had been receiving chronic antihypertensive therapy prior to the study, but a single small oral dose of a beta-adrenergic blocking agent (labetalol, atenolol, or oxprenolol) was given to 89 of them along with premedication. Forty-four per cent of the untreated control patients and 61% of the patients pretreated with a beta-adrenergic blocking agent had normal preoperative electrocardiograms and no risk factors for coronary artery disease other than hypertension (this difference between groups was not statistically significant). During tracheal intubation and/or emergence from anesthesia, a brief, self-limited episode of myocardial ischemia was detected in 11 of 39 untreated control patients, and in two of 89 patients pretreated with a beta-adrenergic blocking agent (P less than 0.001). Tachycardia always accompanied the ischemic events, but a conspicuous increase in blood pressure did not. The authors conclude that mild hypertension, when untreated prior to the induction of anesthesia, is associated with a high incidence of myocardial ischemia; and that a single small oral dose of a beta-adrenergic blocking agent, given with pre-medication, can significantly reduce that risk.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895596

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  21 in total

Review 1.  Advances in nuclear cardiology: preoperative risk stratification.

Authors:  Kenneth A Brown
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

Review 2.  Preoperative evaluation of the cardiac patient for noncardiac surgery.

Authors:  P G Barash
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 3.  How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials.

Authors:  P J Devereaux; W Scott Beattie; Peter T-L Choi; Neal H Badner; Gordon H Guyatt; Juan C Villar; Claudio S Cinà; Kate Leslie; Michael J Jacka; Victor M Montori; Mohit Bhandari; Alvaro Avezum; Alexandre B Cavalcanti; Julian W Giles; Thomas Schricker; Homer Yang; Carl-Johan Jakobsen; Salim Yusuf
Journal:  BMJ       Date:  2005-07-04

4.  Esmolol.

Authors:  J G Ramsay
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

5.  Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery.

Authors:  Hermann Blessberger; Sharon R Lewis; Michael W Pritchard; Lizzy J Fawcett; Hans Domanovits; Oliver Schlager; Brigitte Wildner; Juergen Kammler; Clemens Steinwender
Journal:  Cochrane Database Syst Rev       Date:  2019-09-26

6.  Safer non-cardiac surgery for patients with coronary artery disease. Medical treatment should be optimised to improve outcome.

Authors:  J Sonksen; R Gray; P Hutton; P H Hickman
Journal:  BMJ       Date:  1998-11-21

Review 7.  Controversies in perioperative medicine.

Authors:  H Q Cheng
Journal:  West J Med       Date:  1998-12

Review 8.  The patient with heart disease.

Authors:  J Ramsay
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

Review 9.  Perioperative control of hypertension: when will it adversely affect perioperative outcome?

Authors:  John W Sear
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 10.  Issues in the perioperative management of the elderly patient with cardiovascular disease.

Authors:  John W Sear; Helen Higham
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.